Author Correction: Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management

Nat Rev Clin Oncol. 2022 Nov;19(11):744. doi: 10.1038/s41571-022-00680-8.
No abstract available

Publication types

  • Published Erratum